Literature DB >> 23278861

Osmotic demyelination syndrome associated with hypophosphataemia: 2 cases and a review of literature.

Jessica Turnbull1, Daniel Lumsden, Ata Siddiqui, Jean-Pierre Lin, Ming Lim.   

Abstract

AIM: Central and extrapontine myelinolysis are collectively known as osmotic demyelination syndrome. This encephalopathic illness has been well documented in the adult literature, occurring most commonly in the context of chronic alcoholism, correction of hyponatraemia and liver transplantation. Aetiology and outcome in the paediatric population are less well understood.
METHODS: Two cases of osmotic demyelination syndrome occurring in children with transient severe hypophosphataemia during the course of their illness are presented. Both had very different neurological outcomes, but the changes of central and extrapontine myelinolysis were apparent on neuroimaging. Sixty-one cases in the paediatric literature were then reviewed.
RESULTS: We summarize aetiology and outcome in paediatric cases of osmotic demyelination syndrome and postulate a role for hypophosphataemia as a contributing factor in the development of these sometimes devastating conditions.
CONCLUSION: Hypophosphataemia may contribute to the risk of developing osmotic demyelination syndrome in at-risk paediatric patients and further study of this association should be undertaken. ©2012 The Author(s)/Acta Paediatrica ©2013 Foundation Acta Paediatrica.

Entities:  

Keywords:  Central pontine myelinolysis; Extrapontine myelinolysis; Hyponatraemia; Hypophosphataemia; Osmotic demyelination syndrome

Mesh:

Substances:

Year:  2013        PMID: 23278861     DOI: 10.1111/apa.12143

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

Review 1.  Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?

Authors:  Phuong-Mai T Pham; Phuong-Anh T Pham; Son V Pham; Phuong-Truc T Pham; Phuong-Thu T Pham; Phuong-Chi T Pham
Journal:  Clin Exp Nephrol       Date:  2014-08-24       Impact factor: 2.801

2.  Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions.

Authors:  Palle Bager; Christian L Hvas; Jens F Dahlerup
Journal:  Br J Clin Pharmacol       Date:  2017-01-18       Impact factor: 4.335

Review 3.  Phosphate in the Context of Cognitive Impairment and Other Neurological Disorders Occurrence in Chronic Kidney Disease.

Authors:  Merita Rroji; Andreja Figurek; Davide Viggiano; Giovambattista Capasso; Goce Spasovski
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

4.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

Review 5.  Intravenous iron administration and hypophosphatemia in clinical practice.

Authors:  S Hardy; X Vandemergel
Journal:  Int J Rheumatol       Date:  2015-04-27

6.  Potentially life-threatening phosphate diabetes induced by ferric carboxymaltose injection: a case report and review of the literature.

Authors:  Xavier Vandemergel; Frédéric Vandergheynst
Journal:  Case Rep Endocrinol       Date:  2014-11-13

7.  Pediatric osmotic demyelination syndrome in a case of type 1 diabetes mellitus with diabetic ketoacidosis.

Authors:  Ashlesha Chaudhary; Aashutosh Chaudhary; Radhay Shyam Yadav; Yashaswi Shrestha; Ritu Shah
Journal:  Clin Case Rep       Date:  2022-03-19

8.  A case of osmotic demyelination syndrome occurred after the correction of severe hyponatraemia in hyperemesis gravidarum.

Authors:  Giovanni Corona; Luigi Simonetti; Corinna Giuliani; Alessandra Sforza; Alessandro Peri
Journal:  BMC Endocr Disord       Date:  2014-04-11       Impact factor: 2.763

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.